No QTc Prolongation with Semaglutide: A Thorough QT Study in Healthy Subjects

ConclusionBased on investigations of QT/QTc, no concern with regard to ventricular arrhythmias was raised as semaglutide did not prolong the cardiac repolarization duration in healthy subjects.Trial RegistrationClinicalTrials.gov identifier: NCT 02064348.FundingNovo Nordisk.
Source: Diabetes Therapy - Category: Endocrinology Source Type: research